Batm Advanced Communicat... Share Discussion Threads

[amt] 16/5/2020 15:53

FSE good information thanks.
You ask me what am I talking about.
Basically have these test kits been peer reviewed. Did you see that Porton Down had give the Roche tests a going over before they got approved.
The CE mark is great but isn't necessarily the final step to approval. Here is an extract about the CE marking.

However, especially given the rapid development of the pandemic, the performance of the
device may vary in practice in comparison to the performance study the manufacturer has
done for the purposes of CE-marking. Therefore, it is highly recommended to carry out
additional validation of the clinical performance of tests for COVID-19 by comparison with a
reference method in a sufficiently large number of target population subjects before
introducing the devices into the clinical routine. Scientific peer-reviewed results for the
clinical validation of commercial COVID-19 tests are highly recommended before they can
be safely and reliably used for medical or public health decision making. Validation refers to
confirmation that the test achieves the performance levels specified by the manufacturer.

[gclark] 16/5/2020 15:16

I'm back again on the airports! I see our test having a market at airports.
I think the best case would be 3 stages of testing to reassure passengers: to be checked by a sniffer dog (if that works, results in 6 weeks hopefully) at the entrance, then a temperature test, and a rapid antigen test (such as ours) only for those failing at stage 1 or 2, or who appear to need one/or randomly selected!

The airlines have to take account of potential anxiety amongst passengers, so need to show flying is as risk free as possible, but still allows timely travel.

I don't agree that you give up on a company or a product because another company has won a contract. And I don't think this pandemic is over in any way, yet, and testing will be needed for the foreseeable future so there are big requirements, globally.

[wizzkid211] 16/5/2020 13:49

I value ADALTIS at about 350m usd a six-fold increase from June 2016.
EGENS BIOTCH. CO. paid 3m usd for 5% of ADALTIS valuing it at 58m usd.
June 2016 share price was 16p for the whole of BATM!

[picsous] 16/5/2020 11:00

FSE, thank you for digging that out, it is extremely insightful to see how BATM operate and how much potential for large scale manufacturing and distribution they command.
We don't really know what impact Covid-19 will have on BATM but it would seem that it may well be transformative. I guess the August Interims will give us a better view.

[fse] 15/5/2020 23:38

Its Adaltis and I would expect that this is a licensing arrangement. They are unlikely to manufacture any quantity in Italy. BATM itself is a research and development company primarily that looks for appropriate manufacturers same as Apple does not build or manufacture or even assemble its phones. FWIW

[amt] 15/5/2020 22:27

Picsous I didnt see Adeltis mentioned or is it under a different name

[fse] 15/5/2020 22:03

Deleted still working on a link. Will post later. This post is edited for new content.
Suffice to say that I believe the action with the manufacture of the Serology test is likely under license in China.
I would not have thought any of BATM operatives are large enough to roll out the number of tests which are getting ordered in mind bending numbers.


BATM’s Adaltis to Receive Investment and Enters into Strategic Joint Venture in China
June 30, 2016 02:00 AM Eastern Daylight Time
HOD HASHARON, Israel--(BUSINESS WIRE)--BATM Advanced Communications Limited (LSE: BVC) (“BATM” or “the Group”), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its wholly-owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has entered into an investment agreement and a strategic joint venture with its Chinese partner, Egens Biotechnology Company Ltd. (“Egens”), a leading biotechnology company combining biological material development and diagnostic reagent manufacturing.

Highlights of the transaction

Egens will purchase RMB20m (approximately US$3m) of new shares in Adaltis, equivalent to approximately 5.5% of Adaltis’ enlarged share capital, valuing Adaltis at approximately US$58m


VANCOUVER, British Columbia, May 04, 2020 (GLOBE NEWSWIRE) -- Global Care Capital Corp. (CSE: HLTH, OTC: RSCZF, FRANKFURT: L6V1) (the “Company”; or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that ViraxClear, through its joint venture (“Joint Venture”) Shanghai Biotechnology Devices Ltd. (“SBD”) has on April 30th, 2020, finalized supply contracts with Shanghai CP Adaltis Diagnostics Co., Ltd. (“Shanghai CP”), for the distribution of COVID-19 Antibody Test Kits (the “Test Kits”) manufactured by Innovita Biological Technology Co., Ltd. (“InnovitaR21;), into the European market and a second contract with Shenzhen Qianhai Huolilang Technology Co., Ltd. (“Qianhai̶1;), for the distribution of the Test Kits manufactured by Nanjing Vazyme Biotech Co., (“Vazyme”;), into the European and Singapore markets.

[wizzkid211] 15/5/2020 18:48

hxxps://www.openpr.com/news/2045208/sterilization-equipment-market-top-players-getinge-advanced

Sterilization Equipment Market will exceed USD 9.2 billion by 2024; as per a new research report.

[picsous] 15/5/2020 17:48

Various tests compared:

[fse] 15/5/2020 15:25

amt what in the world are you talking about ? Have you been tested yet,
If you want to post your address here we will get a reliable kit sent to you from Beijing in a brown envelope marked reliable.

Added: FWIW I value BATM IP currently at 85p "without" the Covid19 tests.
Cyber security and NFVTime have huge potential.
Remember BATM have developed all of this in house without having to go to the markets for funding.
They do not have massive bank loans and lines of credit etc.

[rawdeal1] 15/5/2020 15:02

Looks like a good bit of profit taking going on .... healthy.

[paulisi] 15/5/2020 14:37

For me the big interest is in the home test kits for cold, flu and covid.If this get approved and first to market at a reasonable price then this share would really take off.The rest of the businesses are solid even without Covid solutions.

[markyt] 15/5/2020 09:13

Don't go do anything silly when the rapid meningitis tests are implemented all over the world too will you just saying and everybody all over the world want there animal waste disease free too now hmmm

[steeplejack] 15/5/2020 09:05

The company is involved in all the areas that currently transfix the market....5G enhanced communication solutions,defence,cyber security,diagnostic kits and ventilators.The company has a full LSE listing.It has experienced management and good political connections.It is cash generative.Meanwhile the historic PE is around 120x.That's somewhat daunting but since profits could well triple,if not quadruple in due course,the prospective multiple is possibly in the 30s.If you look at the chart,BVC was around the 50p mark a year ago.Things were meaningfully improving before COVID emerged.Its not as if the share price rise has been exponential like Novacyt.All in all,I'm pretty relaxed about holding despite recent share price gains.

[amt] 15/5/2020 08:42

Yes wish I had bought that share. I see their market cap is now about 250m so a bit late to invest and to be fair much of the share price rise was before FDA approval..Its like the dotcom bubble so many companies with tests out there you have to pick the ones that are likely to get approval for use which is a bit of a gamble.

[rawdeal1] 15/5/2020 08:41

Well if we get a 2700% rise from my purchase price average of about 25p, I'll be eyeing up purchase of a Caribbean island.... :))

[markyt] 15/5/2020 08:35

I don't see why this company cant do just as well as ncyt if not more plenty of other sides to the buissness here aswell

[rawdeal1] 15/5/2020 08:16

Short mention of Novacyt in the Mail this am. Revenues have increased 16x on last year, and that's just so far this year. Share price has increased by 2,700% on huge demand for their testing kits.
So, looks like there's something for everyone.

[paulisi] 15/5/2020 08:15

Looks like we have gone through a breakout point.

[markyt] 15/5/2020 08:12

Yawn 1.20 on it's way

[amt] 15/5/2020 07:17

Sometimes investing is taking a punt on something but when it's easy to analyse something I believe it's worth doing. I shall await independent evidence on the Adaltis kit before I buy back in.

[markyt] 14/5/2020 20:39

Think you need to toddle off over to aortech ramp that up abit more get 20% out of um and bring your profit back here zvi could use your cash hes got alot of ramping up to do himself to get the whole world tested and build 30million quids worth of ventilators ohh and theres the 5g thingee too hmmm hes a busy man you know

[amt] 14/5/2020 20:06

I am not saying the Adaltis kit isnt as good as Roche by the way. I just need to see independent evidence.

[amt] 14/5/2020 19:56

There is an article in tonights Telegraph about the possibilty of the Government issuing certificates to individuals who have developed immunity. If immunity can be demonstrated in the months ahead then it's clear that the tests will be performed by professionals to ensure certificates are issued correctly.

[amt] 14/5/2020 19:49

FSE The Roche test has been approved by the EU The US Food and Drug Administration. Furthermore by the UK as in the news today. Please show me a link to show me where the Adaltis approval has been given, which countries, which authorities.
There are numerous links to the Roche test.

The Elecsys Anti-SARS-CoV-2 serology test was approved at the beginning of May by the EU and the US Food and Drug Administration (FDA). It has a 99.8% specificity and 100% sensitivity, and is designed to be used on blood samples taken by a healthcare professional at least 14 days after a person has developed Covid-19.